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abstract: Objectives: This study aimed to determine the relationship between glycaemic control and carotid 
atherosclerotic disease among patients with acute ischaemic stroke (AIS). Methods: This retrospective cross-
sectional study took place in the Neurology Department of King Fahad Hospital of University, Khobar, Saudi Arabia, 
from April to October 2017. Data were collected from the medical records of 244 patients with a diagnosis of AIS 
confirmed by computed tomography. Doppler ultrasounds of the carotid artery were performed to determine the 
presence of increased carotid intima media thickness (CIMT) and plaques. Results: Significantly higher mean 
glycated haemoglobin (HbA1c) levels were noted in cases with high CIMT values (P = 0.002), but not in cases 
with carotid plaques (P = 0.360). In addition, there was a significant association between diabetes mellitus (DM) 
and high CIMT (P = 0.045), but not with carotid plaques (P = 0.075). Finally, while dyslipidaemia and age were 
independently correlated with high CIMT values (P = 0.034 and <0.001, respectively) and carotid plaques (P <0.001 
each), no independent relationships were noted in terms of gender and other risk factors like DM, hypertension 
and smoking (P >0.050 each). Conclusion: High HbA1c levels were associated with high CIMT values, but not with 
carotid plaques. Therefore, HbA1c levels may be useful as an indirect marker of the initial stages of carotid artery 
atherosclerosis.
Keywords: Glycated Hemoglobin A1c; Diabetes Mellitus; Carotid Intima-Media Thickness; Atherosclerotic Plaque; 
Stroke.
بني  ال�شباتي  ال�رسايني  ت�شلب  ومر�ص  الدم  ال�شكر يف  ن�شبة  على  ال�شيطرة  بني  العالقة  ايل حتديد  الدرا�شة  هذه  الهدف: هدفت  امللخ�ص: 
الع�شبية  الأمرا�ص  ق�شم  باأثر رجعي يف  امل�شتعر�شة  الدرا�شة  اأجريت هذه  الطريقة:  الدماغية احلادة.  ال�شكتة  الذين يعانون من  املر�شى 
يف م�شت�شفى امللك فهد التابع جلامعة الإمام عبد الرحمن بن في�شل، اخلرب، اململكة العربية ال�شعودية، يف الفرتة مابني اأبريل اإىل اأكتوبر 
الأ�شعة املقطعية. مت  الدماغية احلادة والثابتة بوا�شطة  244 مري�شا م�شابني بال�شكتة  الطبية ل  ال�شجالت  البيانات من  2017. مت جمع 
النتائج:  والرت�شبات.  ال�شباتي  ال�رسيان  بطانة  �شماكة  زيادة  وجود  لتحديد  ال�شباتي  ال�رسيان  من  دوبلر  ال�شوتية  فوق  املوجات  اإجراء 
 ،)P= 0.002( لوحظ ارتفاع م�شتوى ال�شكر الرتاكمي يف الدم ب�شكل ملحوظ يف احلالت ذات قيم �شماكة بطانة ال�رسيان ال�شباتي العالية
ولكن لي�ص يف احلالت مع تر�شبات ال�رسيان ال�شباتي )P = 0.360(. بالإ�شافة اإىل ذلك، كان هناك ارتباط كبري بني داء ال�شكري وارتفاع 
�شماكة  بطانة ال�رسيان ال�شباتي )P = 0.045(، ولكن لي�ص مع تر�شبات ال�رسيان ال�شباتي )P = 0.075(. واأخريا، يف حني اأن ع�رس �شحميات 
والرت�شبات  التوايل(  0.001<، على  و   P  =  0.034( العالية  ال�شباتي  ال�رسيان  بطانة  �شماكة  قيم  م�شتقل مع  ب�شكل  والعمر مرتبطان  الدم 
ال�شباتية )P >0.001 لكل منهما(، مل تالحظ اأي عالقات م�شتقلة من حيث اجلن�ص وعوامل اخلطر الأخرى مثل داء ال�شكري، ارتفاع �شغط 
الدم والتدخني )P <0.050 لكل منهما(. اخلال�صة: ارتبطت م�شتويات م�شتوى ال�شكر الرتاكمي العالية مع ارتفاع قيم �شماكة بطانة ال�رسيان 
ال�شباتي، ولكن لي�ص مع تر�شبات ال�رسيان ال�شباتي. لذلك، قد تكون م�شتويات ال�شكر الرتاكمي مفيدة كعالمة غري مبا�رسة للمراحل الأولية 
من ت�شلب ال�رسايني ال�شباتية.
الكلمات املفتاحية: م�شتوى ال�شكر الرتاكمي؛ داءال�شكرى؛ �شماكة بطانة ال�رسيان ال�شباتي؛ تر�شبات ال�رسيان؛ ال�شكتة الدماغية.
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Advances in Knowledge
- The association between glycated haemoglobin (HbA1c) and carotid intima-media thickness (CIMT) has been studied in different 
populations. This study demonstrated a relationship between HbA1c and CIMT in patients with ischaemic stroke. 
Application to Patient Care
- The findings of this study may help in the early recognition of carotid artery atherosclerotic disease as well as in the formulation 
of strategies and guidelines for stroke prevention. However, further clinical research regarding different stroke risk factors would be 
beneficial.
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Extracranial carotid artery atherosc- lerotic disease is an important thromboembolic cause of stroke and a key target in stroke prev- 
ention.1 In addition, growing evidence suggests that 
carotid atherosclerotic disease is a risk factor for neuro-
cognitive dysfunction.2 Approximately 30% of ischaemic 
strokes are caused by carotid occlusive disease.3 The 
sensitivity and specificity of a carotid Doppler ultra-
sound—which measures the reduction in carotid dia- 
meter as well as the carotid intima media thick- 
ness (CIMT)—is 90–95%, making it highly sensitive for 
the detection of atherosclerotic plaques.4 According to 
previous research, CIMT increases in patients with diab- 
etes mellitus (DM).5 Moreover, raised glycated haemo- 
globin (HbA1c) levels are related to the risk of carotid 
atherosclerotic plaques as well as their subsequent 
thickening and hardening. Such plaque changes are an 
independent risk factor for stroke, with the risk abruptly 
increasing at an HbA1c level of >7% regardless of a diag- 
nosis of DM.6–8
In addition to predicting overall stroke risk, poor 
glycaemic control also influences functional outcomes 
following an ischaemic stroke. Recovery largely depends 
on the intrinsic rewiring and remapping of damaged 
structures, along with surviving regions. The damage 
induced by chronically altered glycaemic levels is not 
limited to the extracranial large vessels but also involves 
the vascular and neural pathways in the brain.9 The 
effect of chronic hyperglycaemia-induced metabolic dys- 
function on the structure and function of the cerebro-
vascular system leads to impaired blood supply to the 
salvageable penumbra zone through the collateral vessels 
and increases susceptibility to reperfusion injuries. Thus, 
chronic exposure to abnormally high glycaemic levels 
may significantly impair reparative neovascularisation 
and reduce neural circuit functional plasticity.9
The association between HbA1c and CIMT has 
been studied in various populations.10,11 In addition, 
previous studies have analysed the frequency of carotid 
artery stenosis among patients with stroke as well as 
those with severe triple vessel coronary artery disease 
and DM.12,13 Choi et al. studied the association between 
HbA1c levels and arterial stiffness and peripheral 
arterial disease among Korean patients with type 2 DM.14 
However, there is a lack of local data from Saudi 
Arabia analysing the relationship between glycaemic 
control and carotid atherosclerotic disease. This study 
therefore aimed to investigate the relationship between 
elevated HbA1c levels and CIMT and carotid plaques 
in ischaemic stroke patients in Saudi Arabia. This popul- 
ation is susceptible to multiple vascular risk factors as 
well as a rising prevalence of neurocognitive disorders 
and stroke, with evidence of both small vessel disease 
and large vessel occlusion.15,16
Methods
This retrospective cross-sectional study was carried out 
in the Department of Neurology, King Fahad Hospital 
of University, Khobar, Saudi Arabia, between April and 
October 2017. Retrospective data were collected from 
the medical records of 400 adult patients with acute 
ischaemic stroke (AIS) seen at an affiliated hospital 
between February 2010 and September 2016. As per 
the guidelines of the World Health Organization, AIS 
was defined as “rapidly developed clinical signs of focal 
(or global) disturbance of cerebral function, lasting more 
than 24 hours or leading to death, with no apparent cause 
other than of vascular origin”.17 All AIS diagnoses were 
confirmed by cranial computed tomography. Patients 
with isolated transient ischaemic attacks, strokes of card- 
ioembolic aetiology or due to vasculitis syndromes and 
those with coagulation disorders were excluded. Therefore, 
a final sample of 244 patients with AIS were included 
in the study. 
High-resolution B-mode carotid Doppler ultrasono- 
graphy of each patient was performed by a radiologist 
using a MyLab™ Class C® 7 MHz linear transducer 
(Esaote Group, Genoa, Italy), as per international guide- 
lines.18 The CIMT was calculated as the mean maximal 
intima media thickness of each carotid artery measured 
at both the bifurcation and the internal carotid arteries. 
A CIMT value of >0.8 mm was considered high, as this 
cut-off value has been found to correlate with vascular 
risk factors.19,20 A plaque was defined as a localised pro- 
trusion of the internal part of the vessel wall into the 
lumen with a thickness of >1.5 mm between the intima-
lumen and media-adventitia interfaces.21 HbA1c levels 
were measured using high-performance liquid chroma- 
tography with a G8 HPLC Analyser® (Tosoh Bioscience 
Inc., San Francisco, California, USA) as per the National 
Glycohemoglobin Standardization Program guidelines.22 
According to the American Diabetes Association 
criteria, DM was defined as either a fasting glucose level 
of ≥126 mg/dL or an HbA1c level of ≥6.5%.23 Other risk 
factors for stroke and carotid artery disease were also 
noted, such as hypertension (HTN), dyslipidaemia and 
smoking. HTN was defined as a systolic or diastolic 
blood pressure (BP) of >140 mmHg or 90 mmHg, respect- 
ively. Dyslipidaemia was defined as a fasting serum 
cholesterol level of >200 mg/dL, triglyceride level of 
>150 mg/dL, low-density lipoprotein level of >120 mg/dL 
and a high-density lipoprotein level of 35–60 mg/dL.24 
However, a higher HDL cut-off point (<40mg/dL) was 
used when assessing cardiac risk in female patients, 
given the observed incidence of coronary disease in 
women with comparatively higher HDL-C levels than 
men.25
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Data were analysed using the Statistical Package 
for the Social Sciences (SPSS), Version 20.0 (IBM Corp., 
Armonk, New York, USA). The results were presented as 
frequencies and percentages for age, gender, DM, HTN, 
smoking, dyslipidaemia, stroke subtype, high/normal 
CIMT and the presence/absence of carotid plaques 
and means and standard deviations for age and HbA1c 
level. An independent t-test was used to compare means 
and a Chi-squared test was used to compare categorical 
variables. A P value of <0.050 was deemed statistically 
significant. A logistic regression analysis was performed 
to ascertain the effects of age, gender, HTN, dyslipid-
aemia, smoking and HbA1c level on the likelihood of 
high CIMT values and carotid plaques.
Ethical approval for this study was received from 
the Institutional Review Board of Imam Abdulrahman 
Bin Faisal University (#IRB-2017-01026). 
Table 2: Relationship between glycated haemoglobin and 
carotid intima media thickness and carotid plaques in 
acute ischaemic stroke patients (N = 244)
Variable n (%) Mean HbA1c 
level in % ± SD
P value*
CIMT in mm 
>0.8 140 (57.4) 7.8 ± 2.4
0.002
<0.8 104 (42.6) 6.9 ± 1.8
Presence of carotid plaques
Yes 117 (48) 7.5 ± 2.3
0.360
No 127 (52) 7.3 ± 2.2
HbA1c = glycated haemoglobin; SD = standard deviation; CIMT = car- 
otid intima media thickness.
*Using an independent sample t-test.
Table 3: Association between carotid intima media thick- 
ness and carotid plaques presence in acute ischaemic 
stroke patients according to diabetes status (N = 244)







>0.8 88 (62.9) 52 (50)
0.045
<0.8 52 (37.1) 52 (50)
Presence of carotid plaques
Yes 74 (52.9) 43 (41.3)
0.075
No 66 (47.1) 61 (58.7)
CIMT = carotid intima media thickness.
*Using a Chi-squared test. 
Table 1: Demographic and clinical characteristics of 
acute ischaemic stroke patients according to diabetes 








(n = 104) 
Gender
Male 160 (65.6) 93 (66.4) 67 (64.4) 
Female 84 (34.4) 47 (33.6) 37 (35.6) 
Age in years
≤50 74 (30.3) 41 (29.3) 33 (31.7) 
51–60 26 (10.7) 19 (13.6) 7 (6.7) 
61–70 54 (22.1) 32 (22.9) 22 (21.2) 
>70 90 (36.9) 48 (34.3) 42 (40.4) 
Mean ± SD 64.3 ± 14.5 64.4 ± 13.5 64.2 ± 15.9
Range 26–120 34–98 26–120
Risk factors*
HTN 193 (79.1) 118 (84.3) 75 (72.1) 
Dyslipidaemia 185 (75.8) 118 (84.3) 67 (64.4) 
Smoking 49 (20.1) 32 (22.9) 17 (16.3) 
HTN and dyslip-
idaemia
144 (59) 93 (66.4) 51 (49)
HTN and smoking 35 (14.3) 26 (18.6) 9 (8.7)
Dyslipidaemia 
and smoking




31 (12.7) 24 (17.1) 7 (6.7)
Type of stroke
LAA 113 (46.3) 66 (47.1) 47 (45.2)
SVD 131 (53.7) 74 (52.9) 57 (54.8)
CIMT in mm 
>0.8 140 (57.4) 88 (62.9) 52 (50)
<0.8 104 (42.6) 52 (37.1) 52 (50)
Presence of carotid plaques
Yes 117 (48) 74 (52.9) 43 (41.3)
No 127 (52) 66 (47.1) 61 (58.7)
HbA1c level in %
Mean ± SD 7.4 ± 2.2 8.6 ± 2.2 5.7 ± 0.8
Range 3.8–14.0 5.0–14.0 3.8–10.0
SD = standard deviation; HTN = hypertension; LAA = large artery 
atherosclerosis; SVD = small vessel disease; CIMT = carotid intima 
media thickness; HbA1c = glycated haemoglobin.
*Percentages do not add up to 100% as some patients may have had 
several risk factors.
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Results
Overall, 244 patients with AIS were included in the study. 
Of these, 65.6% were male and the mean age was 64.3 
± 14.5 years. Most patients were ≥61 years old (59%). A 
total of 193 patients were hypertensive (79.1%), 185 had 
dyslipidaemia (75.8%), 140 were diabetic (57.4%) and 49 
were smokers (20.1%). Among the diabetics, the prev- 
alence of HTN, dyslipidaemia and smoking was 84.3%, 
84.3% and 22.9%, respectively. There were 93 patients 
(66.4%) with both HTN and dyslipidaemia, 26 smokers 
with HTN (18.6%) and 29 smokers with dyslipidaemia 
(20.7%). In 24 cases, all four risk factors were present 
(17.1%). More than half of the patients (53.7%) had small 
vessel disease, while 46.3% had large artery atherosclerosis. 
High CIMT values were observed in 140 cases (57.4%), 
while carotid plaques were present in 117 (48%). Mean 
HbA1c levels were higher among diabetic patients comp- 
ared to non-diabetic patients (8.6 ± 2.2% versus 5.7 ± 0.8%) 
7.4 ± 2.2% [Table 1]. This difference was statistically 
significant (P <0.001).
In addition, mean HbA1c levels were significantly 
higher in patients with high CIMT values compared 
to those with normal CIMT values (7.8 ± 2.4% versus 
6.9 ± 1.8%; P = 0.002). However, there was no significant 
difference in the mean HbA1c levels of patients with 
carotid plaques compared to those without (7.5 ± 2.3% 
versus 7.3 ± 2.2%; P = 0.360) [Table 2]. Finally, a significant 
association was observed between the frequency of high 
CIMT values and the presence of DM (62.9% versus 50%; 
P = 0.045). However, no significant association was 
found between the frequency of carotid plaques and 
the presence of DM (52.9% versus 41.3%; P = 0.075) 
[Table 3]. 
According to the logistic regression analysis, dyslip-
idaemia (odds ratio [OR]: 2.06, confidence interval [CI]: 
1.05–4.04; P = 0.034), HbA1c levels (OR: 0.81, CI: 
0.68–0.96; P = 0.019) and age (OR: 1.95, CI: 0.87–2.17; 
P <0.001) were independent predictors of high CIMT 
values. Similarly, dyslipidaemia (OR: 2.88, CI: 1.30–6.37; 
P <0.001) and age (OR: 1.87, CI: 0.85–2.05; P <0.001) 
were independently correlated with carotid plaques. 
However, gender (OR: 0.82, CI: 0.44–1.15; P = 0.532), DM 
(OR: 0.78, CI: 0.38–1.60; P = 0.519), HTN (OR: 1.56, 
CI: 0.78–3.10; P = 0.205) and smoking (OR: 1.92, 
CI: 0.88–4.15; P = 0.097) were not independently 
correlated with CIMT. Similarly, gender (OR: 0.72, 
CI: 0.36–1.45; P = 0.367), HbA1c levels (OR: 0.97, 
CI: 0.82–1.16; P = 0.811), DM (OR: 1.41, CI: 0.63–3.15; 
P = 0.401), HTN (OR: 2.10, CI: 0.92–4.78; P = 0.070) 
and smoking (OR: 1.79, CI: 0.77–4.15; P = 0.170) were 
not independently correlated with carotid plaques 
[Table 4].
Discussion
Assessing HbA1c levels is a useful method of determ- 
ining glucose control. Such testing is now recommended 
not only for diagnosing DM and pre-DM, but also for 
predicting cardiovascular risk.26 It has been suggested 
that glucose variability strongly correlates with HbA1c 
levels among elderly male patients with type 2 DM.27 
Fluctuations in glucose levels can harm the arterial wall 
due to oxidative stress and endothelial dysfunction.28 
Furthermore, glycaemic status is strongly associated with 
all grades of carotid artery disease.29 The risk of major 
adverse cardiovascular events is significantly higher 
among type 2 DM patients who have had the disease 
for a long time and who have advanced carotid artery 
stenosis.30
B-mode ultrasonography is a noninvasive method 
of measuring intimal thickness, plaque formation and 
stenosis in the peripheral arteries. An increase in CIMT 
is an early manifestation of carotid artery atheroscler-
osis; this is subsequently followed by plaque formation 
Table 4: Predictors of carotid intima media thickness and carotid plaques in acute ischaemic stroke patients (N = 244)
Risk factor High CIMT* Carotid plaques
Adjusted OR (95% CI) P value Adjusted OR (95% CI) P value
Age 1.95 (0.87–2.17) <0.001 1.87 (0.85–2.05) <0.001
Gender 0.82 (0.44–1.15) 0.532 0.72 (0.36–1.45) 0.367
DM 0.78 (0.38–1.60) 0.519 1.41 (0.63–3.15) 0.401
HTN 1.56 (0.78–3.10) 0.205 2.10 (0.92–4.78) 0.070
Dyslipidaemia 2.06 (1.05–4.04) 0.034 2.88 (1.30–6.37) <0.001
Smoking 1.92 (0.88–4.15) 0.097 1.79 (0.77–4.15) 0.170
HbA1c 0.81 (0.68–0.96) 0.019 0.97 (0.82–1.16) 0.811
Hosmer-Lemeshow goodness-of-fit 0.08 0.45
CIMT = carotid intima-media thickness; OR = odds ratio; CI = confidence interval; DM = diabetes mellitus; HTN = hypertension; HbA1c = glycated haemoglobin.
*A CIMT value of >0.8 mm.
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and then carotid stenosis due to the narrowing of the 
lumen.29,31 Several studies have shown that Doppler 
ultrasonography of the carotid artery can help to predict 
subsequent major adverse cardiovascular events.31,32 
The demographic characteristics of the sample 
included in the present study were similar to those of 
previous research concerning ischaemic stroke patients. 
In accordance with other studies conducted in the Gulf 
region, the majority of patients were male.16,33 Critically, 
30.3% of cases were under 50 years of age, indicating a 
relatively young age of stroke onset. Dyslipidaemia was 
the second most frequent risk factor; however, this 
finding requires further verification with population-
based prospective studies. The prevalence of DM in 
the current study was slightly lower than reported in a 
previous study of AIS patients in Khobar (57.4% versus 
62.7%).16 The mean HbA1c level was comparable to 
that reported by Singh et al. among stroke patients in 
India (7.4 ± 2.2% versus 7.51 ± 1.75%).20
In the current study, high CIMT values and carotid 
artery plaques were present in 57.4% and 48% of cases, 
respectively. The relation between HbA1c levels and 
CIMT and carotid plaques has been addressed in several 
studies. Saha et al. found that the prevalence of high 
CIMT in stroke patients was ≈71%.34 Singh et al. noted 
high HbA1c concentrations in ischaemic stroke patients 
with high CIMT values and carotid plaque while Lee 
et al. noted an increase in CIMT and plaque formation 
among ischaemic stroke patients with DM.20,35 The 
present study similarly found that HbA1c level—as a 
reflection of poor glycaemic control—was significantly 
higher among AIS patients with high CIMT values. In 
contrast, HbA1c level was not significantly associated 
with carotid plaques. This might be due to the high freq- 
uency of HTN and dyslipidaemia in the sample which 
may have confounded the results.
According to a logistic regression analysis, dyslip- 
idaemia was an independent risk factor for both high 
CIMT and plaque formation in the current study. 
Carotid plaque formation is thought to be multifactorial. 
Cardoso et al. reported that type 2 DM, advanced age, 
being male, smoking and ambulatory BP (particularly 
night-time pulse pressure) were the main independent 
predictors of atherosclerosis.36 In another study, Kowall 
et al. concluded that CIMT is highly dependent on 
traditional cardiovascular risk factors; however, the 
association between blood glucose levels and CIMT 
disappears after risk factor adjustment.37
The present study was subject to certain limitations. 
First, as the study was retrospective, the exact duration 
of DM and increased HbA1c levels could not be establ- 
ished. Second, some of the patients had multiple risk 
factors which can confound associations. Performing a 
risk factor adjustment would therefore have strengthened 
the results. Third, data regarding BP variability—which 
affects stroke outcomes in carotid artery occlusion and 
is an important predictor of carotid artery disease—were 
lacking.38,39 Finally, although Doppler ultrasonography 
has high sensitivity, there is nevertheless a risk of operator-
dependent variability. 
Conclusion
Among the studied sample of AIS patients, high HbA1c 
levels were significantly associated with high CIMT 
values, but not with carotid plaques. Accordingly, HbA1c 
may be beneficial as an indirect marker of the initial 
stages of carotid artery atherosclerosis. Further clinical 
studies adjusting for risk factors are recommended 
to determine the true relationship between glycaemic 
control and carotid artery disease.
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